C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus.

By P. Ridker. Journal of the American College of Cardiology, 2007

643 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Surgery

View Paper: https://www.semanticscholar.org/paper/a464c938dc01d515528fea01ddd675f3bfc0417f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. Peter Libby
2. G. Hansson
3. P. Ridker

In Epidemiology

1. Peter Libby
2. P. Ridker
3. G. Hansson
4. T. Thuren
5. A. Zalewski
6. I. Tabas
7. Jongsoon Lee
8. L. Melvin

In Surgery

1. Peter Libby
2. G. Hansson
3. P. Ridker
4. T. Thuren
5. A. Zalewski
6. I. Tabas
7. L. Melvin
8. Jongsoon Lee

Citations in the corpus

• Inflammation in Atherosclerosis: From Pathophysiology to Practice (2009, background): “More than a dozen large-scale prospective cohort studies indicate that hsCRP predicts incident myocardial infarction, stroke, and cardiovascular death even after full adjustment for the traditional Framingham covariates (45).”
• Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS). (2011, background): “factors.(3) Epidemiologic data for hsCRP consistently demonstrate the pathophysiologic importance of inflammation as a target for intervention.”